Jingjing Liu

Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)

Affiliated withThe First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)Zhejiang Chinese Medical University Jilin Cancer Hospital

Research Area

Biography

Jingjing Liu has not added Biography.
If you are Jingjing Liu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title	2025
Publication title	2026

Other Publications

Article	Year
Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cellular & molecular immunology\| PubMed ID: 20921939	2011
Gene silencing of NOB1 by lentivirus suppresses growth and migration of human osteosarcoma cells. Molecular medicine reports\| PubMed ID: 24714960	2014
[Advances of immunotherapy in small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 24949688	2014
[Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 25936888	2015
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy\| PubMed ID: 26799652	2016
Growth inhibition of human gastric adenocarcinoma cells in vitro by STO-609 is independent of calcium/calmodulin-dependent protein kinase kinase-beta and adenosine monophosphate-activated pr... American journal of translational research\| PubMed ID: 27158402	2016
miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1. Cancer medicine\| PubMed ID: 28440026	2017
[Clinical Development of Immune Checkpoint Inhibitors in Patients with Small Cell Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 28935016	2017
[A Reflection of the New Wave of Immunotherapy on the Clinical Study of  Chinese Lung Cancer Immunotherapy]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 29061217	2017
[Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 29167005	2017
A panel consisting of three novel circulating lncRNAs, is it a predictive tool for gastric cancer? Journal of cellular and molecular medicine\| PubMed ID: 29700972	2018
[Research Progress of Immunotherapy for Brain Metastases in Patients  with Drive Gene Negative NSCLC]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 30172268	2018
[Advances on Recognizing and Managing Tumor Heterogeneity]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 30201072	2018
Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review. OncoTargets and therapy\| PubMed ID: 30863087	2019
Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review). International journal of oncology\| PubMed ID: 30896792	2019
Regulation Mechanism of Long Noncoding RNAs in Colon Cancer Development and Progression. Yonsei medical journal\| PubMed ID: 30900417	2019
Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated ... Journal of clinical laboratory analysis\| PubMed ID: 31282096	2019
Current Understanding of Circular RNAs in Gastric Cancer. Cancer management and research\| PubMed ID: 31853202	2019
Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR-ANXA2, EGFR-RAD51, ATR and BRCA2 mutations: A case report. Thoracic cancer\| PubMed ID: 31865638	2020
The effect of PD-L1/PD-1 immunotherapy in the treatment of squamous non-small-cell lung cancer: a meta-analysis of randomized controlled clinical trials. Journal of thoracic disease\| PubMed ID: 31903233	2019
Factors related to rapid progression of non-small cell lung cancer in Chinese patients treated using single-agent immune checkpoint inhibitor treatment. Thoracic cancer\| PubMed ID: 32134200	2020
A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer. Anti-cancer drugs\| PubMed ID: 32694423	2020
[Highlights of PAPR Inhibitors in Small Cell Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 32752582	2020
Pretreatment prognostic nutritional index is a prognostic marker for extensive-stage small cell lung cancer patients treated with anlotinib. Journal of thoracic disease\| PubMed ID: 33209408	2020
[Chinese Experts Consensus on Immune Checkpoint Inhibitors  for Non-small Cell Lung Cancer (2020 Version)]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 33896153	2021
Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer. Chinese medical journal\| PubMed ID: 34133356	2021
CHSY1 is upregulated and acts as tumor promotor in gastric cancer through regulating cell proliferation, apoptosis, and migration. Cell cycle (Georgetown, Tex.)\| PubMed ID: 34412565	2021
Highly expressed IFITM10 is associated with early diagnosis and T stage of gastric cancer. Translational cancer research\| PubMed ID: 35116268	2021
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China. Thoracic cancer\| PubMed ID: 36127731	2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer. Thoracic cancer\| PubMed ID: 36444143	2023
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors. Thoracic cancer\| PubMed ID: 36924056	2023
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma. Thoracic cancer\| PubMed ID: 37461124	2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China. Thoracic cancer\| PubMed ID: 37718634	2023
An advanced NSCLC patient with and fusions treated with -TKI combination therapy: a case report. Translational lung cancer research\| PubMed ID: 38205210	2023
Expert Consensus on the Diagnosis and Treatment of Gene Fusion Solid Tumors. Global medical genetics\| PubMed ID: 38414979	2024
Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma. Frontiers in medicine\| PubMed ID: 38482526	2024
The predictive value of E2F7 in immunotherapy efficacy for lung adenocarcinoma: An observational study. Medicine\| PubMed ID: 38905387	2024
[PKM1 Regulates the Expression of Autophagy and Neuroendocrine Markers  in Small Cell Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 39492579	2024
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations. Innovation (Cambridge (Mass.))\| PubMed ID: 39529955	2024
Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors. Global medical genetics\| PubMed ID: 39583123	2024
Mutation-guided chemotherapy-free strategy in first-line immunotherapy for low PD-L1-expressing non-squamous NSCLC. Journal for immunotherapy of cancer\| PubMed ID: 39615893	2024
Metastatic sites, prognosis, and a new nomogram for predicting overall survival among small cell lung cancer patients with liver metastasis: a retrospective study based on SEER. Journal of thoracic disease\| PubMed ID: 39975725	2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration. Cancer biology & medicine\| PubMed ID: 40200811	2025
Clinical Benefit of PD-1/PD-L1 Inhibitors as Standard First-Line Treatment in Low PD-L1-Expressing Advanced Solid Tumors: A Systematic Review and Meta-Analysis. MedComm\| PubMed ID: 41675360	2026
Expert consensus on the detection and clinical application of tumor mutational burden. Cancer biology & medicine\| PubMed ID: 41704094	2026
International guidelines on the diagnosis and treatment of NUT carcinoma. Innovation (Cambridge (Mass.))\| PubMed ID: 41737331	2026